Delivery Order SPE2DB24D2011-SPE2DB24FBQPM
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $1,018.25 firm fixed-price delivery order is for 4566437277 GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,119.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4 mg Glimepiride tablets in 100-count bottles. The contract has an ultimate completion date of January 27, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,073.81, is a Delivery Order for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,690.42 firm fixed-price delivery order covers the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,530.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (SPE2DB22D1041|SPE2DB25FTYP7) for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a Delivery Order worth $1,176.98 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is for 4,567,171,215 tablets of the drug Glimepiride 4 mg. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB20D1110|SPE2DB24FK30R, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,100.33 Firm Fixed Price delivery order contract is for the supply of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,322.54 Firm Fixed Price Delivery Order is for the provision of 4,564,326,421 tablets of the pharmaceutical drug Glimepiride 4 mg. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, SPE2DX15D2216|SPE2DX23F26A6, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $19,111.09 firm fixed-price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used in the treatment of diabetes. The contract has a performance period through September 26, 2023 and does not utilize any set-aside designations. Amerisourcebergen holds a $999,999,999...
This federal contract award, valued at $1,480.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566779276 - Glimepiride 2 mg Tablets in 100-count bottles. It is a firm-fixed-price delivery order contract with a completion date of December 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...